Trial drug ineffective in preventing contrast-induced kidney injury
Patients treated with CMX-2043—an investigational drug that has previously shown some ability to protect heart muscle from damage during stenting—saw no improved protection in their kidneys compared to placebo, according ...
Apr 4, 2016
0
0